MDPI and ACS Style
Royal, A.; John, D.; Bharti, O.; Tanwar, R.; Bhagat, D.K.; Padmawati, R.S.; Chaudhary, V.; Umapathi, R.; Bhadola, P.; Utarini, A.
Reply to Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on “Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88”. Vaccines 2023, 11, 807.
https://doi.org/10.3390/vaccines11040807
AMA Style
Royal A, John D, Bharti O, Tanwar R, Bhagat DK, Padmawati RS, Chaudhary V, Umapathi R, Bhadola P, Utarini A.
Reply to Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on “Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88”. Vaccines. 2023; 11(4):807.
https://doi.org/10.3390/vaccines11040807
Chicago/Turabian Style
Royal, Abhishek, Denny John, Omesh Bharti, Ritesh Tanwar, Deepak Kumar Bhagat, Retna Siwi Padmawati, Vishal Chaudhary, Reddicherla Umapathi, Pradeep Bhadola, and Adi Utarini.
2023. "Reply to Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on “Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88”" Vaccines 11, no. 4: 807.
https://doi.org/10.3390/vaccines11040807
